Skip to content
Home/Companies/Biotech/Biovitrum

Biovitrum

Biotech·Sweden·Exited 2006·Held 5yr
Entry
2001
Hold
5yr
Exit
2006

Who owns Biovitrum?

Biovitrum was owned by Nordic Capital through Nordic Capital (early funds) (1991 vintage) from 2001 to 2006, exited via IPO.

Hand-verified · updated 2026-08-18

Nordic Capital
Investor
Nordic Capital
Nordic Capital (early funds) · 1991 · Buyout

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2006

More from Nordic Capital (early funds)

Other portfolio companies in the same fund.

Bufab
Exited 2014
IndustrialsSweden· 2005
Cloetta
Exited 2013
ConsumerSweden· 2005
FinnvedenBulten
Exited 2011
MobilitySweden· 2005
Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.)
Exited 2012
PharmaUS· 2005
to
Kompan
Exited 2014
ConsumerDenmark· 2005
to
Luvata
Exited 2014
IndustrialsFinland· 2005
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Biovitrum

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Biovitrum?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Biovitrum.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue